This site is for informational purposes only and does not provide medical advice, diagnosis, or treatment. Always consult your healthcare provider.
Bacillus Subtilis and Enterococcus Faecium Probiotic Plus Lipid-Lowering Therapy for Hypertriglyceridemic Acute Pancreatitis: A Prospective RCT | MicrobiomeTrials
← Back to trials NCT07720232
Bacillus Subtilis and Enterococcus Faecium Probiotic Plus Lipid-Lowering Therapy for Hypertriglyceridemic Acute Pancreatitis: A Prospective RCT Recruiting PHASE4 INTERVENTIONAL
Read the full scientific description See full eligibility requirements Trial Details Start: 2026-01-18Est. Completion: 2028-01-18
Enrollment target: 180 participantsLocations Department of Gastroenterology, Zhongshan Hospital, Xiamen University, Xiamen, Fujian, China Other microbiome trials you might be interested in Hypertriglyceridemia Induced Acute Pancreatitis Recurrent Acute Pancreatitis Pancreatitis Relapsing Hypertriglyceridemia
Hypertriglyceridemia-induced acute pancreatitis (HTG-AP) is associated with a high risk of recurrence despite standard l…
Beijing, China Est. completion Sep 2028
Hypertriglyceridemia, Familial
The study will evaluate safety and tolerance of intravenous delivery of GC304 gene therapy drug as a treatment of primar…
Beijing, China Est. completion Dec 2026